uracil has been researched along with Organophosphorus Poisoning in 1 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saifina, LF | 3 |
| Abdalla, M | 3 |
| Gubaidullina, LM | 3 |
| Zueva, IV | 3 |
| Eltayb, WA | 3 |
| El-Arabey, AA | 3 |
| Kharlamova, AD | 3 |
| Lenina, OA | 3 |
| Semenov, VE | 3 |
| Petrov, KA | 3 |
1 other study available for uracil and Organophosphorus Poisoning
| Article | Year |
|---|---|
Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Kinetics; Myastheni | 2023 |
Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Kinetics; Myastheni | 2023 |
Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Kinetics; Myastheni | 2023 |
Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Kinetics; Myastheni | 2023 |